A Wake-Up Call for the Health Industry: Billions at Stake if Consumer Needs are Ignored
In a bold statement, Deloitte's 2026 Life Sciences and Health Care Outlook report reveals a potential financial disaster for the industry if it fails to meet the growing demands of consumers. With a staggering $168 billion on the line, the report highlights a critical juncture where consumer expectations are outpacing industry action.
Who's Behind the Report?
Kulleni Gebreyes, a board member of Deloitte US and a leading voice in the Life Sciences and Health Care industry, emphasizes the importance of this outlook for executives and boards as they navigate the complexities of the health economy.
The Numbers Don't Lie
Over $168 Billion at Risk: Deloitte's analysis, utilizing the Komodo Healthcare Map™, estimates that health systems could lose up to $54.5 billion, and biopharma companies could lose a massive $114.1 billion over the next decade if they fail to adapt.
The Consumer vs. Executive Priorities: While consumers prioritize convenience, access, and affordability, less than half of biopharma and medtech executives, and even fewer health plan and health system executives, share these priorities.
AI Adoption Gap: Despite almost 50% of consumers already using generative AI for health reasons, only 15% of LSHC executives claim their organizations have adapted governance to keep up with technology. Additionally, 48% of LSHC executives acknowledge a lack of representation on their boards in areas like AI and data science.
Trust: The Ultimate Differentiator: With 63% of consumers willing to switch doctors due to communication dissatisfaction, and only 13% trusting biopharma companies for reliable treatment information, trust emerges as a critical factor. Deloitte's analysis of HundredX™ data reveals that organizations with high trust levels enjoy 2.5 times higher customer loyalty.
A Turning Point for the Health Economy
As consumer expectations surge, the 2026 Outlook signals a pivotal moment for the $4.5 trillion U.S. health economy. Startups and tech entrants are swiftly filling gaps left by traditional providers, and life sciences companies are embracing direct-to-consumer models to reduce friction. Consumer trust and organizational agility have become the new benchmarks for competitiveness.
Key Strategies for Success
- Redesign Care with the Consumer in Mind: Instead of relying on legacy enterprise models, organizations must prioritize the consumer experience.
- Earn Trust through Transparency and Personalization: Building and maintaining trust is crucial for long-term success.
- Adapt Governance for Technological Change: Keeping pace with technology, rather than tradition, is essential to stay relevant.
The Future of Health Care
In the coming years, data will be the new infrastructure, and trust will be the new currency. Health systems, biopharma firms, and medtech leaders must evolve to avoid losing market share and consumer confidence.
About Deloitte:
Deloitte, a global leader in professional services, serves a diverse range of clients, including nearly 90% of the Fortune 500® and over 8,500 U.S.-based private companies. With a network spanning over 150 countries, Deloitte strives to make a meaningful impact on its people, clients, and communities. For more information, visit www.deloitte.com.
